Viewing Study NCT06744920

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 4:15 AM
Ignite Modification Date: 2026-01-17 @ 10:12 AM
Study NCT ID: NCT06744920
Status: RECRUITING
Last Update Posted: 2025-12-17
First Post: 2024-12-17
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: A Study to Investigate the Efficacy, Safety and Tolerability of Remibrutinib Versus Placebo in Adult Patients With Generalized Myasthenia Gravis
Sponsor: Novartis Pharmaceuticals
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Generalized Myasthenia Gravis View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Myasthenia Gravis View
None gMG View
None Generalized Myasthenia Gravis View
None LOU064 View
None Remibrutinib View
None placebo-controlled View
None double-blind View
None phase III View